β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia

Mice deficient in the zinc-sensor GPR39, which has been demonstrated to protect cells against endoplasmatic stress and cell death in vitro, display moderate glucose intolerance and impaired glucose-induced insulin secretion. Here, we use the Tet-On system under the control of the proinsulin promoter...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristoffer L. Egerod, Chunyu Jin, Pia Steen Petersen, Nils Wierup, Frank Sundler, Birgitte Holst, Thue W. Schwartz
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2011/401258
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561800964472832
author Kristoffer L. Egerod
Chunyu Jin
Pia Steen Petersen
Nils Wierup
Frank Sundler
Birgitte Holst
Thue W. Schwartz
author_facet Kristoffer L. Egerod
Chunyu Jin
Pia Steen Petersen
Nils Wierup
Frank Sundler
Birgitte Holst
Thue W. Schwartz
author_sort Kristoffer L. Egerod
collection DOAJ
description Mice deficient in the zinc-sensor GPR39, which has been demonstrated to protect cells against endoplasmatic stress and cell death in vitro, display moderate glucose intolerance and impaired glucose-induced insulin secretion. Here, we use the Tet-On system under the control of the proinsulin promoter to selectively overexpress GPR39 in the β cells in a double transgenic mouse strain and challenge them with multiple low doses of streptozotocin, which in the wild-type littermates leads to a gradual increase in nonfasting glucose levels and glucose intolerance observed during both food intake and OGTT. Although the overexpression of the constitutively active GPR39 receptor in animals not treated with streptozotocin appeared by itself to impair the glucose tolerance slightly and to decrease the β-cell mass, it nevertheless totally protected against the gradual hyperglycemia in the steptozotocin-treated animals. It is concluded that GPR39 functions in a β-cell protective manner and it is suggested that it is involved in some of the beneficial, β-cell protective effects observed for Zn++ and that GPR39 may be a target for antidiabetic drug intervention.
format Article
id doaj-art-d147df460811438080b301bd70c244b7
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-d147df460811438080b301bd70c244b72025-02-03T01:24:13ZengWileyInternational Journal of Endocrinology1687-83371687-83452011-01-01201110.1155/2011/401258401258β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced HyperglycemiaKristoffer L. Egerod0Chunyu Jin1Pia Steen Petersen2Nils Wierup3Frank Sundler4Birgitte Holst5Thue W. Schwartz6Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen, DenmarkLaboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen, DenmarkLaboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen, DenmarkDivision of Diabetes, Metabolism, and Endocrinology, Department of Experimental Medical Science, Lund University, Lund, SwedenDivision of Diabetes, Metabolism, and Endocrinology, Department of Experimental Medical Science, Lund University, Lund, SwedenLaboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen, DenmarkLaboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen, DenmarkMice deficient in the zinc-sensor GPR39, which has been demonstrated to protect cells against endoplasmatic stress and cell death in vitro, display moderate glucose intolerance and impaired glucose-induced insulin secretion. Here, we use the Tet-On system under the control of the proinsulin promoter to selectively overexpress GPR39 in the β cells in a double transgenic mouse strain and challenge them with multiple low doses of streptozotocin, which in the wild-type littermates leads to a gradual increase in nonfasting glucose levels and glucose intolerance observed during both food intake and OGTT. Although the overexpression of the constitutively active GPR39 receptor in animals not treated with streptozotocin appeared by itself to impair the glucose tolerance slightly and to decrease the β-cell mass, it nevertheless totally protected against the gradual hyperglycemia in the steptozotocin-treated animals. It is concluded that GPR39 functions in a β-cell protective manner and it is suggested that it is involved in some of the beneficial, β-cell protective effects observed for Zn++ and that GPR39 may be a target for antidiabetic drug intervention.http://dx.doi.org/10.1155/2011/401258
spellingShingle Kristoffer L. Egerod
Chunyu Jin
Pia Steen Petersen
Nils Wierup
Frank Sundler
Birgitte Holst
Thue W. Schwartz
β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia
International Journal of Endocrinology
title β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia
title_full β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia
title_fullStr β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia
title_full_unstemmed β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia
title_short β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia
title_sort β cell specific overexpression of gpr39 protects against streptozotocin induced hyperglycemia
url http://dx.doi.org/10.1155/2011/401258
work_keys_str_mv AT kristofferlegerod bcellspecificoverexpressionofgpr39protectsagainststreptozotocininducedhyperglycemia
AT chunyujin bcellspecificoverexpressionofgpr39protectsagainststreptozotocininducedhyperglycemia
AT piasteenpetersen bcellspecificoverexpressionofgpr39protectsagainststreptozotocininducedhyperglycemia
AT nilswierup bcellspecificoverexpressionofgpr39protectsagainststreptozotocininducedhyperglycemia
AT franksundler bcellspecificoverexpressionofgpr39protectsagainststreptozotocininducedhyperglycemia
AT birgitteholst bcellspecificoverexpressionofgpr39protectsagainststreptozotocininducedhyperglycemia
AT thuewschwartz bcellspecificoverexpressionofgpr39protectsagainststreptozotocininducedhyperglycemia